Occupational health risk management in semiconductor manufacturing requires more than routine exposure measurements. It also depends on reliable health systems, transparent chemical information, attention to historical and emerging risks, and a process for checking whether improvements are carried out. The Samsung Ombudsperson Commission offers an example of how independent oversight can bring these elements together in a complex production environment.
Established through an agreement among Samsung Electronics, the workers’ rights group SHARPs, and a family compensation committee, the Commission was tasked with reviewing occupational accident management and health risks at semiconductor and liquid crystal display (LCD) facilities. Its work followed a long-running dispute over claims that workplace conditions had contributed to leukemia and other diseases among employees. The Commission’s findings and recommendations were presented as a comprehensive diagnosis, followed by a commitment to monitor implementation.
Why independent review was established
The agreement behind the Commission called for a complete system to support a healthy and safe workplace. That goal extended beyond technical controls: it included organizational culture, communication with independent public-interest institutions, and a stronger internal occupational health management system.
The Commission’s role was to assess the company’s existing systems and recommend changes, not simply to take measurements at individual workstations. It reviewed information supplied by the company, requested additional data where needed, and conducted site inspections. Its scope covered workplace hazards, health effects, occupational health programs, prevention policies, and the handling of information about potentially harmful chemicals.
What the comprehensive diagnosis examined
A group of specialists organized the review across five areas. This structure linked industrial hygiene and exposure assessment with worker health, company systems, research, and chemical-information governance.
- Physical and chemical agents: Review of workplace conditions, chemical management, exposure monitoring, and plans for improvement.
- Health effects: Review of epidemiological research, studies of workers, and interviews with current and former employees.
- Occupational health systems: Assessment of health management and employee support programs.
- Prevention research: Review of scientific literature, policies, and practices in other countries.
- Chemical information: Assessment of how safety data and information about substances are shared and archived, including consideration of trade-secret claims.
Between late 2016 and 2017, the investigation covered Samsung semiconductor and LCD sites in Giheung, Hwaseong, Onyang, and Asan. Results were presented publicly in 2018, with the comprehensive report later revised to reflect stakeholder feedback.
Exposure findings and limits of the evidence
In the work environment data reviewed for the three most recent years, many of the substances investigated were not detected at the sites. For detected substances, reported levels were below 10% of Korean occupational exposure limits. Testing of selected photoresist samples found some targeted chemicals absent and others at levels the report characterized as negligible. Measurements relating to electromagnetic fields were also below 10% of the recommended level, while radiation equipment management and estimated worker exposure were reported as meeting applicable safety requirements.
These measurements describe the conditions and samples assessed; they do not resolve every question about past exposure. Interviews with former and current workers raised the possibility of exposure to chemicals, noise, and odors in older processes that differ from current operations. Because some facilities or processes had already been shut down, the historical conditions could not be confirmed directly. The review also found that current processes had become highly automated, with workers no longer directly exposed to chemicals or harsh environments in the same way described for earlier procedures.
A review and meta-analysis of available research could not verify occupational links between semiconductor work and several cancers and other diseases considered. Biomarker results for current workers’ exposure to substances such as benzene and arsenic were broadly similar to levels found in the general population. The report therefore distinguished between what the available evidence could establish and the uncertain risks that still merited preventive attention.
Turning findings into preventive action
The Commission recommended improvements intended to address both ongoing management needs and uncertainty about future health risks. Several actions are relevant to plant operators and engineering teams:
- Continue monitoring exposures, including in preventive maintenance work, and regularly assess recirculated air in cleanrooms.
- Strengthen analysis of key harmful substances and develop a job-exposure matrix to organize exposure information by work and job history.
- Establish worker cohorts and conduct biological exposure studies to support longer-term health research.
- Expand health promotion and occupational health support, including programs tailored to employees with chronic diseases.
- Consider a health, safety, and environment risk-management system using big-data analysis and artificial intelligence, as proposed in the report.
- Improve communication among internal and external stakeholders and provide stronger safety and health support for partner companies.
- Share information on chemicals used in facilities and strengthen the archiving of employee health data, while keeping protection of trade secrets from compromising workers’ right to know.
The recommendations reflect a key operational principle: measurement is only one part of prevention. Exposure records, health data, worker communication, and clear accountability all help organizations identify patterns and act on risks that may not be immediately measurable.
Oversight must continue after the assessment
The Commission’s work included monitoring the company’s progress on improvement plans, with annual reviews and the option to request further information or site inspections. That follow-through is essential because a diagnosis has limited value if corrective actions are not assigned, implemented, and reviewed over time.
For semiconductor and LCD operations, the practical lesson is to combine industrial hygiene controls with robust health management, long-term exposure tracking, transparent chemical information, and independent review where appropriate. The diagnosis did not verify occupational correlations for the diseases examined, but it identified ways to strengthen prevention despite unresolved questions. Sustained monitoring and clear communication can help organizations manage uncertainty while continuing to protect workers.